Pharma Pulse 3/11/24: Yogurt May Reduce Diabetes Risk, Tech Evangelist's Dreams for AI Tutors Might be Too Big & more


The latest news for pharma industry insiders.

Yunu Co-Founders Discuss Improving Efficiency and Accuracy in Clinical Trials

Jeff Sorenson and Gael Kuhn, Co-founders, Yunu, talk about ways their company has improved efficiency and accuracy in clinical trials for clients such as NCI designated cancer centers.

Guiding Women Within Health Care and the Significance of Self-Development, Improvement

The vice president and chief pharmacy officer at City of Hope explains how she serves as a mentor for women within health care, the importance of networking, and staying educated.

US FDA allows new claim that yogurt may reduce diabetes risk

The U.S. Food and Drug Administration on Friday said it would allow yogurt makers to say that the dairy product may reduce the risk of type 2 diabetes as more Americans die from the disease and take medications like Ozempic to battle it.

This Tech Evangelist Has Big Dreams for AI Tutors. Are They Too Big?

Sal Khan says the technology could save education, but the gains he hopes for haven’t been seen in modern research

@US_FDA on Twitter/X:

Today, we approved a new indication for use for an injectable medication to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular disease and either obesity or overweight.

This injection should be used in addition to a reduced calorie diet and increased physical activity.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs

© 2024 MJH Life Sciences

All rights reserved.